Searched for
STELARA SALES DECLINE
JNJ stock price today: Why Johnson & Johnson shares dropped despite strong 2026 forecast? Here's what investors are watchingJNJ stock price today: Johnson & Johnson stock saw a dip even as the company projected robust 2026 sales and profit figures. Legal issues, ...- Johnson & Johnson earnings beat estimates on strong cancer drug salesJohnson & Johnson's first-quarter revenue and profit exceeded Wall Street expectations, driven by strong cancer drug sales. The company rai...
- S&P, Nasdaq muted as bond yields rise; UnitedHealth boosts DowBoth the S&P 500 and the Nasdaq are nearly 4% off from record high levels reached last month, as traders sharply readjusted their expectati...
- Decoding the impact of Ilumya, Sun Pharma's first biologic drug approved by the US FDALast year Sun Pharma signed another deal with South Korea's Samsung Biologics to get the drug manufactured on approval.
Load More